Most cited papers from Sendai Kousei Hospital

Sendai Kousei Hospital

What are the most cited papers from Sendai Kousei Hospital?

The most cited paper from Sendai Kousei Hospital is "Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR" (Makoto Maemondo et al., 2010), with 5,607 citations. Next come "Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial" (1,524) and "Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial" (733).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 110 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR Makoto Maemondo et al. · New England Journal of Medicine	23 Jun 2010	5,607
2	Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial Enriqueta Felip et al. · The Lancet	20 Sep 2021	1,524
3	Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial Noriyuki Katsumata, Makoto Yasuda, Fumiaki Takahashi et al. · The Lancet	19 Sep 2009	733
4	Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial Haruhiro Saito et al. · The Lancet Oncology Open access	8 Apr 2019	646
5	Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study Silvia Novello, Dariusz Mirosław Kowalski, Alexander Valerievich Luft et al. · Journal of Clinical Oncology Open access	3 Feb 2023	562
6	Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology Open access	12 Sep 2012	556
7	Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial Toshiaki Takahashi, Takeharu Yamanaka, Takashi Seto et al. · The Lancet Oncology	23 Mar 2017	553
8	Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash et al. · JAMA Oncology Open access	29 Oct 2020	500
9	Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study Yukio Hosomi, Satoshi Morita, Shunichi Sugawara et al. · Journal of Clinical Oncology	4 Nov 2019	495
10	Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology	13 Aug 2013	485
11	Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology Open access	27 Dec 2018	373
12	Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial Chigusa Morizane et al. · Annals of Oncology Open access	26 Sep 2019	338
13	Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Hirotoshi Watanabe et al. · JAMA Cardiology Open access102 authors	2 Mar 2022	324
14	Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement Tetsuro Shimura et al. · Circulation Open access	16 Mar 2017	309
15	Automatic detection of erosions and ulcerations in wireless capsule endoscopy images based on a deep convolutional neural network Tomonori Aoki, Atsuo Yamada, Kazuharu Aoyama et al. · Gastrointestinal Endoscopy	25 Oct 2018	306
16	Classification and Clinical Impact of Restenosis After Femoropopliteal Stenting Atsushi Tosaka, Yoshimitsu Soga, Osamu Iida et al. · Journal of the American College of Cardiology Open access	19 Dec 2011	305
17	Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima et al. · The Oncologist Open access	22 Jun 2018	298
18	Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402 Akira Inoue, Shunichi Sugawara, Koichi Yamazaki et al. · Journal of Clinical Oncology	14 Oct 2008	236
19	Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis Tsuyoshi Ozawa, Soichiro Ishihara, Mitsuhiro Fujishiro et al. · Gastrointestinal Endoscopy	24 Oct 2018	232
20	Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study Myung‐Ju Ahn et al. · Journal of Clinical Oncology Open access161 authors	9 Sep 2024	226
21	Sex Steroid Hormone Receptors in Human Thymoma Hironori Ishibashi, Takashi Suzuki, Satoshi Suzuki et al. · The Journal of Clinical Endocrinology & Metabolism Open access	May 2003	223
22	Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q Satoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa et al. · Journal of Thoracic Oncology Open access	14 Jan 2014	206
23	Accumulation of p62/ SQSTM 1 is associated with poor prognosis in patients with lung adenocarcinoma Daisuke Inoue, Takashi Suzuki, Yoichiro Mitsuishi et al. · Cancer Science Open access	9 Feb 2012	206
24	Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study Masahito Shimizu, Yasushi Fukutomi, Mitsuo Ninomiya et al. · Cancer Epidemiology Biomarkers & Prevention	Nov 2008	205
25	Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer Shunichi Sugawara, J.-S. Lee, Jin‐Hyoung Kang et al. · Annals of Oncology Open access	15 Jun 2021	204
26	Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi et al. · JAMA Oncology Open access	13 Jan 2021	188
27	Occupational eye dose in interventional cardiology procedures Yoshihiro Haga, Koichi Chida, Yuji Kaga et al. · Scientific Reports Open access	28 Mar 2017	188
28	Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai et al. · Hepatology Open access	9 Jun 2021	183
29	Short‐term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘Real‐world evidence’ in Japan Haruhisa Suzuki et al. · Digestive Endoscopy Open access	30 Jul 2018	183
30	Occupational Dose in Interventional Radiology Procedures Koichi Chida, Yuji Kaga, Yoshihiro Haga et al. · American Journal of Roentgenology	19 Dec 2012	178
31	Automatic detection and classification of protruding lesions in wireless capsule endoscopy images based on a deep convolutional neural network Hiroaki Saito, Tomonori Aoki, Kazuharu Aoyama et al. · Gastrointestinal Endoscopy	18 Feb 2020	175
32	Progesterone Receptor in Non–Small Cell Lung Cancer—A Potent Prognostic Factor and Possible Target for Endocrine Therapy Hironori Ishibashi, Takashi Suzuki, Satoshi Suzuki et al. · Cancer Research	15 Jul 2005	174
33	Artificial intelligence using a convolutional neural network for automatic detection of small‐bowel angioectasia in capsule endoscopy images Akiyoshi Tsuboi, Shiro Oka, Kazuharu Aoyama et al. · Digestive Endoscopy	8 Aug 2019	171
34	An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial Masahiro Natsuaki et al. · Circulation	23 Nov 2023	166
35	ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer David Planchard, Niels Reinmuth, С. В. Орлов et al. · Annals of Oncology Open access	21 Feb 2020	166
36	Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study Hirotsugu Kenmotsu, Kazushige Wakuda, Keita P. Mori et al. · Journal of Thoracic Oncology Open access	27 May 2022	162
37	Diagnostic and Therapeutic Endoscopic Retrograde Cholangiography Using a Short-Type Double-Balloon Endoscope in Patients With Altered Gastrointestinal Anatomy: A Multicenter Prospective Study in Japan Masaaki Shimatani, Hisashi Hatanaka, Hirofumi Kogure et al. · The American Journal of Gastroenterology Open access	27 Sep 2016	161
38	Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer Akira Okita, Shinʼ ichi Takahashi, Kota Ouchi et al. · Oncotarget Open access	9 Apr 2018	157
39	Intervertebral disc degeneration associated with lumbosacral transitional vertebrae Takato Aihara, Kazuhisa Takahashi, A. Ogasawara et al. · Journal of Bone and Joint Surgery - British Volume Open access	26 Apr 2005	156
40	Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset Yuichiro Ohe, Fumio Imamura, Naoyuki Nogami et al. · Japanese Journal of Clinical Oncology Open access	26 Nov 2018	154
41	Two-Year Life Expectancy in Patients With Critical Limb Ischemia Yoshimitsu Soga, Osamu Iida, Mitsuyoshi Takahaera et al. · JACC: Cardiovascular Interventions Open access	Dec 2014	153
42	Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non–Small-Cell Lung Cancer With EGFR Mutation (IMPACT) Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi et al. · Journal of Clinical Oncology	2 Nov 2021	151
43	Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial Yasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto et al. · Journal of Clinical Oncology	20 Apr 2021	147
44	Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial Kazuomi Kario et al. · Hypertension Research Open access	15 Oct 2021	145
45	The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: A prospective study in Japan Shino Oba, Natsuki Shimizu, Chisato Nagata et al. · Cancer Letters	7 Mar 2006	137
46	A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Seiji Habara, Masashi Iwabuchi, Naoto Inoue et al. · American Heart Journal Open access	13 Aug 2013	136
47	The Accuracy and Performance of the A&D TM 2421, a New Ambulatory Blood Pressure Monitoring Device Based on the Cuff-Oscillometric Method and the Korotkoff Sound Technique Yutaka Imai, Shuichi Sasaki, Naoyoshi Minami et al. · American Journal of Hypertension	Oct 1992	134
48	3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia Osamu Iida et al. · JACC: Cardiovascular Interventions Open access	Sep 2015	134
49	A New Echocardiographic Method for Identifying Vortex Flow in the Left Ventricle: Numerical Validation Tokuhisa Uejima, Akira Koike, Hitoshi Sawada et al. · Ultrasound in Medicine & Biology	10 Apr 2010	132
50	Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2 Naota Taura, Tatsuki Ichikawa, Hisamitsu Miyaaki et al. · Gastroenterology Research and Practice Open access	2012	129

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.